曹式丽从风论治IgA肾病经验

发布时间：2018-05-07 23:28

本文选题：曹式丽 + 从风论治　；参考：《辽宁中医杂志》2017年07期

【摘要】：IgA肾病(IgAN)作为全球范围内常见的肾脏疾病,目前约占我国肾小球疾病发病的20%~30%,罹患人群往往在发病10~20年间进入终末期肾病(ESRD)阶段,对于该病的诊疗长期作为肾脏病领域临床与科研的重点与难点问题。全国名老中医药专家、全国老中医药专家学术经验继承工作指导教师、天津市名中医曹式丽教授,长期致力于以IgA肾病为代表的慢性肾脏病的中医临床证候特征、病机演变规律与优势辨治方案的筛选工作,在临床实践中逐步形成了特色中医学术思想,"从风论治"IgA肾病便是曹式丽教授中医药特色辨治思维与用药规律的重要组成部分。文章基于国家中医药管理局"曹式丽全国名老中医药专家传承工作室"系统开展的曹式丽教授中医肾病学术经验整理与挖掘研究成果,对曹式丽教授从风论治IgA肾病的学术经验予以初步阐释。
[Abstract]:As a common kidney disease in the world, IgA nephropathy accounts for about 20% of the glomerular diseases in China. The patients often enter the stage of end-stage renal disease (ESRD) in 10 to 20 years. The diagnosis and treatment of the disease has long been the focus and difficulty of clinical and scientific research in the field of kidney disease. The national famous old Chinese medicine expert, the national old Chinese medicine expert academic experience inheriting the work instruction teacher, Tianjin famous Chinese medicine professor Cao Shili, long-term devotes to take the IgA nephropathy as the representative chronic kidney disease Chinese medicine clinical syndrome characteristic, The law of pathogenesis evolution and the screening of superiority differentiation and treatment schemes have gradually formed the academic thought of characteristic Chinese medicine in clinical practice. "treating from wind" IgA nephropathy is an important part of professor Cao Shili's thinking of distinguishing treatment from wind and the law of drug use. This article is based on the research results of Professor Cao Shili's academic experience of TCM nephropathy, which was carried out by the National Administration of traditional Chinese Medicine "Cao Shili National famous traditional Chinese Medicine expert inheritance Studio". Professor Cao Shili's academic experience in treating IgA nephropathy from wind is preliminarily explained.
【作者单位】：天津中医药大学第一附属医院;
【基金】：天津市中医药管理局中医、中西医结合科研专项课题(13075) 国家自然科学基金(30772808);国家自然科学基金(81503509)
【分类号】：R249;R277.5

【参考文献】